shu-508 and Kidney-Neoplasms

The early and functional evaluation of new treatments in oncology is a main goal. At present, technical advances in Doppler ultrasonography allow the detection of neovascularization for superficial and deep malignant tumours in order to evaluate the efficiency of new treatments such as antiangiogenic molecules. Contrast agents injection improves the efficiency of this technique and developments of perfusion softwares optimize this detection. Slow flows in tumour microvessels can be detected. Treatment response can be early predicted based on changes in the vascularization before volume modification. The availability of quantification softwares operating from the raw data before their compression for video display affords one and objective quantification of the contrast agent uptake.

Topics: Antineoplastic Agents; Benzamides; Contrast Media; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Kidney Neoplasms; Microcirculation; Neoplasms; Neovascularization, Pathologic; Phospholipids; Piperazines; Polysaccharides; Pyrimidines; Sulfur Hexafluoride; Treatment Outcome; Ultrasonography

To assess the value of a microbubble-based ultrasonographic contrast agent for enhancing blood vessels in colour Doppler imaging (CDI) of small renal masses.. Fifty-one patients with small renal masses (< 3 cm in diameter) had prospective CDI before and after intravenous administration of the contrast agent Levovist (Schering, Berlin, Germany). The degree of tumour vascularity was subjectively graded from 0 to IV (indicating an increasing vessel count). Furthermore, peak systolic velocity (PSV), resistive index, and pulsatility index were measured. The CDI findings were then compared with those obtained at histopathological examination.. Intra- and/or peritumoral vessels were detected in 26 lesions (51%) by unenhanced CDI and in 48 by enhanced CDI (94%; P = 0.006, McNemar test). Higher grades of tumour vascularity (grade III and IV) were more common in malignant renal masses (P < 0.01). There were PSVs of >80 cm/s only in malignant lesions. Based on receiver operating characteristic analysis, enhanced CDI (area under the curve 0.789) was more accurate than unenhanced CDI (0.576) for differentiating benign from malignant renal masses (P < 0.004).. Enhanced CDI is better than unenhanced CDI for detecting tumour vascularity, and for discriminating between benign and malignant small renal masses.

Topics: Adult; Aged; Contrast Media; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Polysaccharides; Prospective Studies; Ultrasonography, Doppler, Color

Tumoral growth is an angiogenesis-dependent event. Although there are studies about the importance of histopathologic angiogenesis in various malignancies, the assessment of the angiogenesis by radiologic techniques is not well established. The aim of this study was to investigate the efficacy of echo contrast-enhanced power Doppler ultrasonography (PDUS) in determining the angiogenic status of renal cell carcinoma (RCC).. Power Doppler ultrasonography was performed before and after intravenous administration of an echo contrast agent in 42 patients with renal masses. Twenty-one of these renal masses were diagnosed as RCC histopathologically, and these 21 patients were reevaluated retrospectively. The color pixel ratios of selected images were calculated as the ratio of the number of pixels showing power Doppler signals to the total number of pixels within the lesion. The results were compared with the histopathologic microvessel density (MVD).. A significant correlation was found between color pixel ratio and MVD values in both PDUS techniques. The use of the echo contrast agent improved this correlation and P values (Spearman rho from 0.436 to 0.551; P from .048 to .01).. Color pixel ratio values reflect the MVD in RCC. Therefore, these results suggest that preoperative quantification of angiogenesis can be possible with the help of PDUS in RCC.

Topics: Adult; Aged; Carcinoma, Renal Cell; Female; Humans; Image Processing, Computer-Assisted; Kidney Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Polysaccharides; Ultrasonography

The aim of this article is to describe the current ultrasound (US) contrast agents employed in the characterization of renal tumors and to report our experience in the use of a contrast-specific ultrasound technique pulse inversion harmonic imaging (PIHI).A total of 23 renal masses were prospectively evaluated by conventional US, CDUS, PIHI and finally by helical-CT (HCT). The study was performed using a wideband convex array 2-5 MHz transducer and a US digital apparatus . PIHI scanning of each renal mass was performed before and after the injection of Levovist. To reach a definitive diagnosis HCT and/or histological findings were considered as the reference procedures. Eleven solid renal cell carcinomas (RCCs), one embryonal metanephric adenoma (EMA), seven angiomyolipomas (AMLs), and four cystic RCCs were analyzed. Solid RCCs revealed a higher contrast enhancement than AMLs with a typical pattern on conventional US. The EMA and AML with an atypical pattern revealed intense contrast enhancement during the arterial phase, progressively decreasing during the delayed phase. Cystic RCCs showed intense contrast enhancement on the peripheral thick wall during the arterial phase decreasing during the delayed phase. PIHI with Levovist may differentiate solid RCCs from AMLs with no hypervascular pattern while solid RCCs show a higher intensity of contrast enhancement than hypervascular AML.

Topics: Aged; Aged, 80 and over; Contrast Media; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Polysaccharides; Prospective Studies; Ultrasonography

Our objective was to evaluate whether contrast-specific ultrasound (US) technique pulse inversion harmonic imaging (PIHI) with Levovist could reveal differential morphological features in solid and cystic renal masses. Twenty-six renal masses in 26 patients were evaluated by PIHI after Levovist injection with intermittent high mechanical index stimulation, performed every 10-15 s during arterial and delayed phase. Helical CT (HCT; n=6) or histological findings on surgical/bioptic specimen ( n=20) were considered as the reference procedures for definitive diagnosis. Eleven solid renal cell carcinomas (RCCs), 1 embryonal matanephric adenoma (EMA), 7 angiomyolipomas (AMLs), 4 cystic RCCs and 3 complex inflammatory cysts were identified. Solid RCCs revealed a much higher ( p<0.05) contrast enhancement than AMLs with typical pattern on conventional US ( n=6). The EMA and AML with atypical pattern on conventional US ( n=1) revealed intense contrast enhancement during arterial phase, progressively decreasing during delayed phase. Cystic RCCs and complex inflammatory cysts revealed intense contrast enhancement on the peripheral thick wall during arterial phase decreasing on delayed phase. The PIHI has been shown to differentiate solid RCC from typical AML by contrast enhancement assessment after Levovist injection, but differential diagnosis both in solid and in cystic renal masses still remains difficult.

Topics: Aged; Angiomyolipoma; Carcinoma, Renal Cell; Contrast Media; Female; Humans; Kidney Diseases, Cystic; Kidney Neoplasms; Male; Polysaccharides; Tomography, Spiral Computed; Ultrasonography

We evaluated the efficacy of contrast-enhanced color Doppler ultrasonography with a galactose-based echo contrast agent, Levovist, for the diagnosis of renal mass lesions. The final pathologic diagnosis of eight renal mass lesions was renal cell carcinoma in 6 patients, transitional cell carcinoma in 1 patient and renal cyst in 1 patient (age range, 47 to 77 years; mean, 59.1). Especially in patients with renal cell carcinoma, contrast-enhanced color Doppler ultrasonography showed enhancement of mass lesion blood flow signal intensities. In all patients, contrast enhancement was demonstrated. Diagnostic capacity was improved in all patients, excluding 2 in whom mass lesion blood flow was detected by plain color Doppler ultrasonography. Furthermore, in patients with transitional cell carcinoma, the hemodynamics of mass lesions could be visualized, and diagnostic capacity was high. Contrast-enhanced color Doppler ultrasonography with Levovist, showed markedly higher mass lesion blood flow than that obtained by the plain color Doppler procedure, improving diagnostic capacity. This procedure was useful for diagnosing renal mass lesions.

Topics: Aged; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Contrast Media; Female; Humans; Kidney Diseases, Cystic; Kidney Neoplasms; Male; Middle Aged; Polysaccharides; Ultrasonography, Doppler, Color

To evaluate the diagnostic potential of echo-enhanced ultrasonography (US) for depicting the vascularization pattern of renal cell carcinoma (RCC), and calculating the first-pass effect using harmonic imaging, against that obtained by triphasic helical computed tomography (CT).. Sixty patients with surgically confirmed RCC underwent US using B-mode and power Doppler methods with or without an intravenous microbubble echo-enhancing agent. After depicting and defining the tumour extent by B-mode US, the first-pass effect/enhancement by the echo-enhancing agent within the lesion, and that of a reference area of unaffected renal cortex, were recorded on-line by calculating the mean pixel intensity. Time-intensity curves, i.e. the rise time and gradient of both the suspected tumour and reference areas, were constructed.. Using B-mode US, the extent of all tumours was delineated (mean tumour size 3.8 cm, SD 0.6). After applying the microbubble agent all tumours were enhanced, whereas the perfusion was decreased (in 48%), increased (in 16%) or similar (in 36%) compared with the cortical reference area. Using the Hounsfield classification, these results correlated well with the hypo/hypervascularity shown on CT.. Ultrasonography has considerable potential in diagnosing RCC, if combined with echo-enhancing methods, harmonic imaging and computer-based calculation of tumour vascularization. Dynamic US studies should provide a diagnostic yield similar to that of CT.

Topics: Carcinoma, Renal Cell; Contrast Media; Diagnosis, Computer-Assisted; Humans; Kidney Neoplasms; Neovascularization, Pathologic; Pilot Projects; Polysaccharides; Ultrasonography, Doppler, Color

The term "pseudotumor" is used to refer to several anatomic variants that can simulate a renal mass, the most frequent of which are hypertrophied column of Bertin, persistence of fetal lobation, and the dromedary or splenic hump. We describe the findings of power Doppler US after the ultrasound contrast agent (Levovist, Schering, Berlin, Germany) administration in 4 patients with a renal focal lesion in whom gray-scale and baseline power Doppler US was not able to certainly differentiate pseudotumor from neoplasm.

Topics: Adult; Carcinoma, Renal Cell; Contrast Media; Diagnosis, Differential; Female; Humans; Image Enhancement; Kidney; Kidney Diseases; Kidney Neoplasms; Male; Middle Aged; Polysaccharides; Ultrasonography, Doppler

The purpose of this study was to evaluate the feasibility of microvascular imaging using contrast-enhanced color and power Doppler sonography. Ten patients with a focal lesion of the kidney were examined. Three patients were investigated with the polymeric butylcyanacrylate-based contrast agent SHU 563A, and the remaining patients were investigated with the galactose-based agent Levovist. It was possible to observe the microvascularization with Levovist during the blood pool phase of the agent over a period of 1 to 3 s at 1 min and 2 min after injection. With SHU 563A, microvascular imaging was possible 0.50 s after injection and lasted for 10.35 min. No intratumoral signals were seen in cysts (n = 6) and the investigated abscess. Weak intratumoral polychromatic effects were observed in both renal cell carcinomas in this series. Metastasis could be differentiated from healthy parenchyma due to lack of the polychromatic effect. SHU 563A is appropriate for performing microvascular imaging. The Levovist-induced polychromatic effects are smaller, of shorter duration, and observable only during the blood pool phase; thus, the expected diagnostic benefit is limited.

Topics: Blood Vessels; Carcinoma, Renal Cell; Contrast Media; Enbucrilate; Female; Humans; Injections; Kidney Neoplasms; Male; Polymers; Polysaccharides; Prospective Studies; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color

To report the results of a prospective study investigating the potentials of contrast-enhanced power Doppler in the diagnosis of expansive renal lesions.. From 1997 to October 30, 1999, we studied 59 expansive renal lesions (28 malignant, 31 benign) in 48 patients (mean age 55 years, range 10-79) with power Doppler US before and after the administration of an echo-enhancing agent (Levovist, Schering AG, Berlin, Germany). We identified 5 patterns of vascular architecture of the lesions, both before and after contrast agent administration, following the classification by Jinzaki e Coll.. Power Doppler US showed vascular structures in 34 patients. The administration of Levovist revealed vessels in 12/25 lesions which had none at baseline studies and in 6 cases vascularity was particularly evident. Color signals were enhanced in all the 34 vascularized lesions, which allowed better definition of vascular patterns. The characterization of vascular patterns with baseline power Doppler US helped improve diagnostic accuracy compared to gray-scale US (58% versus 32%) for hyperechoic lesions, complex cysts and pseudomasses. Independent of contrast agent administration, the integration of gray-scale and power Doppler modes increased diagnostic accuracy even further (76% correct diagnoses).. In our series, the US contrast agent did not increase the diagnostic accuracy of power Doppler in the differential diagnosis of hyperechoic renal lesions; conversely, Levovist can be advantageous for the characterization of suspected pseudomasses and complex cysts.

Topics: Adolescent; Adult; Aged; Angiolipoma; Carcinoma; Child; Contrast Media; Cysts; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Polysaccharides; Prospective Studies; Ultrasonography, Doppler

The objective of this study was to investigate the potential usefulness of contrast-enhanced power Doppler ultrasonography in the differentiation of benign and malignant cystic renal lesions. Our study group was limited to patients who had complex cystic renal lesions of uncertain malignancy at screening ultrasonography. During the previous 6 months, 485 patients have been referred to ultrasonography for evaluation of renal cystic lesions, but only 13 patients participated in this study. Focusing on tumor vascularity in the intracystic septa or solid component, we analyzed power Doppler sonographic images before and after intravenous injection of contrast agent and compared them with contrast-enhanced CT scans or MR images and pathologic results. The visualization of vascularity was best on contrast-enhanced power Doppler sonography (n = 7). The use of contrast agent with power Doppler sonography showed improved diagnostic accuracy (77%) that was superior to non-contrast-enhanced power Doppler sonography or contrast-enhanced CT. In conclusion, contrast-enhanced power Doppler sonography provides better visualization of tumor vascularity in complicated cystic renal lesions than other imaging modalities, leading to more exact differential diagnosis. We therefore expect that this imaging modality might be very useful in differential diagnosis of problematic cystic renal lesions, benign or malignant.

Topics: Adult; Blood Vessels; Contrast Media; Diagnosis, Differential; Female; Humans; Image Enhancement; Injections, Intravenous; Kidney Diseases, Cystic; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Polysaccharides; Radiographic Image Enhancement; Single-Blind Method; Tomography, X-Ray Computed; Ultrasonography, Doppler

At present, we have two methods of enhanced ultrasonography in the diagnosis of renal tumors. One is the ultrasound B-mode imaging enhancement under renal arterial infusion of carbon dioxide microbubbles, a contrast agent for US, and the other is the color Doppler signal enhancement under intra-venous injection of galactose-based echo contrast agent, SH/TA-508. Renal cell carcinoma were imaged from the very beginning of the injection of CO2 through the time complete washout from the kidney. On the other, intra-tumor color Doppler signals were remakedly emphasized after SH/TA-508 administration. Enhanced ultrasonography is useful in the detection of small renal cell carcinoma and differential diagnosis of renal masses.

Topics: Aged; Carbon Dioxide; Carcinoma, Renal Cell; Contrast Media; Humans; Image Enhancement; Infusions, Intravenous; Kidney Neoplasms; Male; Middle Aged; Polysaccharides; Ultrasonography, Doppler

Topics: Contrast Media; Humans; Kidney Diseases; Kidney Neoplasms; Polysaccharides; Ultrasonography

This study was aimed at assessing the diagnostic value of a new intravenous contrast agent SH U 508 A (Levovist) in improving color Doppler detection of renal mass vascularity. The study included 30 patients with renal masses: 22 adenocarcinomas, 1 sarcoma, 1 leiomyosarcoma, 1 urothelioma, 1 hemorrhagic cyst and 4 angiomyolipomas. The vascularization of the renal masses was investigated by means of color Doppler US, before and after the intravenous injection of SH U 508 A (Levovist), on the basis of blood flow patterns within and around the lesions. At precontrast scanning, low color Doppler signal at the periphery or within the lesions was observed in 13/30 patients only. After contrast administration, the signal-to-noise ratio increased, which allowed the visualization of tumor vessels in 26/30 patients. In 4/30 patients only no major enhancement of tumor vessels was observed. Our experience suggests that SH U 508 A (Levovist) improves color Doppler sensitivity in depicting the tumor vessels which were missed at baseline exams and in evaluating renal vein and inferior vena cava involvement.

Topics: Color; Contrast Media; Evaluation Studies as Topic; Humans; Kidney Neoplasms; Polysaccharides; Ultrasonography